Montaudon D - Search Results

1

Synthesis and antiproliferative activity of aryl- and heteroaryl-hydrazones derived from xanthone carbaldehydes.

Varache-Lembège M, Moreau S, Larrouture S, Montaudon D, Robert J, Nuhrich A. Varache-Lembège M, et al. Among authors: montaudon d. Eur J Med Chem. 2008 Jun;43(6):1336-43. doi: 10.1016/j.ejmech.2007.09.003. Epub 2007 Sep 15. Eur J Med Chem. 2008. PMID: 17949859

2

Determinants of the cytotoxicity of irinotecan in two human colorectal tumor cell lines.

Pavillard V, Agostini C, Richard S, Charasson V, Montaudon D, Robert J. Pavillard V, et al. Among authors: montaudon d. Cancer Chemother Pharmacol. 2002 Apr;49(4):329-35. doi: 10.1007/s00280-001-0416-0. Epub 2002 Jan 30. Cancer Chemother Pharmacol. 2002. PMID: 11914913

3

Inhibition of topoisomerase I cleavage activity by thiol-reactive compounds: importance of vicinal cysteines 504 and 505.

Montaudon D, Palle K, Rivory LP, Robert J, Douat-Casassus C, Quideau S, Bjornsti MA, Pourquier P. Montaudon D, et al. J Biol Chem. 2007 May 11;282(19):14403-12. doi: 10.1074/jbc.M611673200. Epub 2007 Mar 12. J Biol Chem. 2007. PMID: 17355975 Free article.

4

Differential stabilization of topoisomerase-II-DNA cleavable complexes by doxorubicin and etoposide in doxorubicin-resistant rat glioblastoma cells.

Montaudon D, Pourquier P, Denois F, de Tinguy-Moreaud E, Lagarde P, Robert J. Montaudon D, et al. Eur J Biochem. 1997 Apr 15;245(2):307-15. doi: 10.1111/j.1432-1033.1997.00307.x. Eur J Biochem. 1997. PMID: 9151958 Free article.

5

Relationships between DNA damage and growth inhibition induced by topoisomerase II-interfering drugs in doxorubicin-sensitive and -resistant rat glioblastoma cells.

de Tinguy-Moreaud E, Pourquier P, Montaudon D, Robert J. de Tinguy-Moreaud E, et al. Among authors: montaudon d. Anticancer Res. 1994 Jan-Feb;14(1A):99-103. Anticancer Res. 1994. PMID: 8166463

6

Effects of the combination of camptothecin and doxorubicin or etoposide on rat glioma cells and camptothecin-resistant variants.

Pavillard V, Kherfellah D, Richard S, Robert J, Montaudon D. Pavillard V, et al. Among authors: montaudon d. Br J Cancer. 2001 Sep 28;85(7):1077-83. doi: 10.1054/bjoc.2001.2027. Br J Cancer. 2001. PMID: 11592782 Free PMC article.

7

Protein arginine (N)-methyl transferase 7 (PRMT7) as a potential target for the sensitization of tumor cells to camptothecins.

Verbiest V, Montaudon D, Tautu MT, Moukarzel J, Portail JP, Markovits J, Robert J, Ichas F, Pourquier P. Verbiest V, et al. Among authors: montaudon d. FEBS Lett. 2008 Apr 30;582(10):1483-9. doi: 10.1016/j.febslet.2008.03.031. Epub 2008 Mar 31. FEBS Lett. 2008. PMID: 18381071 Free article.

8

Chromosomal modifications of a rat glioblastoma cell line during the acquisition and reversal of doxorubicin resistance.

Montaudon D, Benchekroun MN, Londos-Gagliardi D, Robert J. Montaudon D, et al. Anticancer Res. 1990 Nov-Dec;10(6):1667-75. Anticancer Res. 1990. PMID: 2285241

9

Development of mechanisms of protection against oxidative stress in doxorubicin-resistant rat tumoral cells in culture.

Benchekroun MN, Catroux P, Montaudon D, Robert J. Benchekroun MN, et al. Among authors: montaudon d. Free Radic Res Commun. 1990;11(1-3):137-44. doi: 10.3109/10715769009109676. Free Radic Res Commun. 1990. PMID: 1963616

10

Doxorubicin-induced alterations of c-myc and c-jun gene expression in rat glioblastoma cells: role of c-jun in drug resistance and cell death.

Pourquier P, Montaudon D, Huet S, Larrue A, Clary A, Robert J. Pourquier P, et al. Among authors: montaudon d. Biochem Pharmacol. 1998 Jun 15;55(12):1963-71. doi: 10.1016/s0006-2952(98)00006-9. Biochem Pharmacol. 1998. PMID: 9714316

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters